Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

May 20, 2021

Axonics® Receives FDA Approval Further Expanding MRI Labeling

May 18, 2021

Axonics® Announces CE Mark Approval for Implantable Sacral Neurostimulator that Significantly Extends Recharge Interval

May 14, 2021

Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock

May 11, 2021

Axonics® Announces Upsize and Pricing of Public Offering of Common Stock

May 11, 2021

Axonics® Announces Proposed Public Offering of Common Stock

May 06, 2021

Axonics® Reports First Quarter 2021 Financial Results

Apr 22, 2021

Axonics® to Participate in the BofA Securities 2021 Virtual Healthcare Conference

Apr 15, 2021

Axonics® to Report First Quarter 2021 Financial Results on May 6, 2021

Mar 03, 2021

Axonics® to Participate in the Barclays Global Healthcare Conference

Mar 02, 2021

Axonics® Announces Strategic Alliance for the Manufacture of New Non-Rechargeable Implantable Sacral Neuromodulation Device

Pagination

Current page 1
Page 2
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2021 Axonics, Inc. Axonics^® is a trademark of Axonics, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap